Stem cells have shown tremendous promise for understanding and treating a range of intractable diseases, lesiones y otras condiciones relacionadas con la salud. Se están realizando ensayos clínicos con células madre para muchas afecciones, and each day moves researchers closer to another medical breakthrough.

Stem cells have demonstrated encouraging potential as reparative therapy for patients

The current review summarises the current evidence for use of stem cell therapies. The safety and feasibility of administering different types of stem cell therapies seem to be reasonably proven and all clinical data included in the Global DataBase ClinicalTrials.gov (Estados Unidos)

https://clinicaltrials.gov/ct2/results?term=autologous+ mesenchymal+stem+cells&Search=Apply&recrs=e&age_v=&gndr=&type=&rslt=

We examined the reports of clinical trials in the NIH ClinicalTrials.gov and European databases to classify them by stem cell type and disease application.

We searched for clinical trial data published in peer-reviewed journals and sought out publically available information on trials performed by companies. Data for some studies are regularly published, but for many trials data are unavailable or not easily accessed. Given the relative immaturity of the cell therapy field, it is important to know the outcomes of early clinical trials to help guide others in the processes.

MSCs for Liver Disease and Diabetes

Liver in end stage liver disease (cirrosis) due to hepatitis B and C and alcoholic and cryptogenic causes showed some response in function as assessed by changes in creatinine, serum albumin, and bilirubin in response to autologous MSCs (El-Ansary et al., 2012, Kharaziha et al., 2009).


The anti-fibrotic effects of autologous MSCs (which were 50 million MSCs administered on two occasions 4 weeks apart) were explored in patients with alcoholic liver cirrhosis (Jang et al., 2014). Improvements in histological liver biopsy samples were observed in 55% patients as well as some change in type-1 collagen and α-smooth muscle actin.



Diabetes is classified into two main types (escribe 1 y escriba 2) which both lead to hyperglycemia .

Types of diabetes

  1. Escribe 1 Diabetes is the result of a person’s immune system fighting and destroying the b-cells, it usually begins in the early stages of life and accounts for 10% of the total cases of diabetes. People with this type have to take insulin shots daily in order to survive.
  2. Escribe 2 Diabetes results from b-cell performance decline and an increase in insulin resistance; this type is linked with genetic factors and obesity, hence this type can be prevented by living a healthy lifestyle.
  3. There is another type of diabetes that affects pregnant women, it is called Gestational Diabetes where the hormones released by the placenta to sustain the pregnancy, make the pregnant woman’s cells more resistant to insulin. Once the pancreas is unable to overcome the resistance, the patient develops diabetes

Diabetes Tratamiento con células madre

A través de los años, there have been attempts to cure diabetes by using methods like replacing b-cells through transplants, by increasing b-cell replication, by reducing the death of b-cells and by deriving new b-cells from other cells.

Autologous Mesenchymal stem cells (MSC) are self-renewing multipotent cells that have the capacity to secrete multiple biologic factors that can restore and repair injured tissues.

It is known that MSCs play a crucial role in healing damaged tissues. They can differentiate to replace the dead cells as well as secrete stimulant factors to activate surrounding cells in the microenvironment, enhancing the tissue repair process. Por lo tanto, MSCs can be applied to treat tissues impaired by chronic hyperglycemia. MSC transplantation can increase beta cell mass via the following effects:

(1) beta cell replacement through cellular differentiation;

(2) local microenvironment modification by production of cytokines, chemokines and factors to stimulate endogenous regeneration;

(3) reduction or prevention of autoimmunity to beta cells. Immunomodulatory and inflammatory effects of MSCs also contribute to the reduction of insulin resistance.

Results achieved with terapia con células madre

  • Significant decrease in fasting blood sugars and the level of Hemoglobin A1C
  • Significant decrease in Triglyceride levels
  • Measurable improvement in kidney function with a decrease in creatinine levels

Clinical studies are underway using MSCs in patients with diabetes.

Data suggest positive changes in metabolic parameters may occur with intravenous injection MSCs

It is known that MSCs play a crucial role in healing damaged tissues. They can differentiate to replace the dead cells as well as secrete stimulant factors to activate surrounding cells in the microenvironment, enhancing the tissue repair process

The recent progress in regenerative medicine, especially terapia con células madre, has suggested several novel and potential cures for (Diabetes Type 1) T1D. Autologous mesenchymal stem cell (MSC) based cell therapy is among one of them. MSCs are a type of adult stem cells residing in bone marrow, y otras células madre se han aplicado en la reparación del daño del cartílago clínico con resultados satisfactorios, estimular la autoproliferación de las células progenitoras, and many other tissues. MSC, with self-renewal potential and transdifferentiation capability, can be expanded in vitro and directed to various cell lineages with relatively less efforts. MSCs have well-characterized hypoimmunogenicity and immunomodulatory effect. All these features make MSCs attractive for treating T1D.

For both T1DM and T2DM, autologous MSC transplantation can dramatically improve the blood glucose levels, while reducing the insulin dose and side effects associated with DM. More importantly, both in preclinical trials and clinical trials, autologous MSC transplantation has been demonstrated to be safe; there have been no observed adverse side effects or tumorigenesis. The data thus far have suggested that MSC transplantation is a promising therapy for DM


https://clinicaltrials.gov/ct2/show/NCT01719640?term=autologous+autologous mesenchymal+stem+cells&recrs=e&draw=8&rank=80

https://clinicaltrials.gov/ct2/show/NCT01759823?term=autologous+autologous mesenchymal+stem+cells&recrs=e&draw=9&rank=84

Efficacy of autologous stem cell transplantation in patients with type 2 diabetes mellitus.

Our observations indicate that SCT is a safe and effective modality of treatment to improve beta-cell function in patients with T2DM.


MSC treatment demonstrated exciting therapeutic effects on glycemic control by restoring islet function and ameliorating insulin resistance

Stem cell therapies in clinical trials in stroke


Osteoarthritis and knee pain

Feasibility and safety were confirmed, and strong indications of clinical efficacy were identified. Patients exhibited rapid and progressive improvement of algofunctional indices that approached 65% para 78% por 1 y el menor espesor se observa en. MSC therapy may be a valid alternative treatment for chronic knee osteoarthritis. The intervention is simple, does not require hospitalization or surgery, provides pain relief, and significantly improves cartilage quality.

Intra-articular injection of MSCs in osteoarthritic patients resulted in strong improvement in cartilage coverage and quality in the vast majority of treated cases (Orozco et al., 2013)


Dolor de espalda

Patients with severe back pain due to degenerative disc disease improved dramatically, con 71% of optimal efficiency in the improvement of clinical parameters of pain and disability, but without disc height recovery (Orozco et al., 2011).


Mesoblast has also reported the benefits of a single injection of MSCs (6 o 18 million) in a randomized, placebo-controlled phase II study of 100 patients with chronic low back pain due to degenerative disc disease. A single injection of 6 million MSCs gave substantial and sustained pain relief with 48% having no or minimal pain after 24 months compared with only 13% of patients without pain who received saline control injections (Mesoblast, 2015)

Disfuncion erectil

Clinical trial results show that stem cells can restore sufficient erectile function to allow previously impotent men to have spontaneous intercourse. This is the first time terapia con células madre has produced patients who have recovered sufficient erectile function to enable intercourse.


En 2016, Haahr et al from Denmark reported on the safety and potential effect of a stem cells injection of autologous ADSCs


Esclerosis múltiple

More than half of patients with multiple sclerosis have progressive disease characterised by accumulating disability. The absence of treatments for progressive multiple sclerosis represents a major unmet clinical need. On the basis of evidence that autologous mesenchymal stem cells have a beneficial effect in acute and chronic animal models of multiple sclerosis, we aimed to assess the safety and efficacy of these cells as a potential neuroprotective treatment for secondary progressive multiple sclerosis.

Autologous autologous mesenchymal stem cells were safely given to patients with secondary progressive multiple sclerosis in our study. The evidence of structural, functional, and physiological improvement after treatment in some visual endpoints is suggestive of neuroprotection.


Tratamiento con células madre para la enfermedad de Lyme

Cerebro, sistema nervioso, corazón, circulación, músculos, articulaciones, sistema reproductivo, La digestión y la piel son algunas áreas del cuerpo que son el objetivo de la enfermedad de Lyme crónica.. A veces, los síntomas tardan incluso años en aparecer y es imposible predecir cuándo pueden aparecer.. Estas dificultades son muy difíciles de resolver., dejar a un paciente con dolor y discapacitado para las actividades diarias habituales.

Nuevo terapia con células madre es un descubrimiento que es extremadamente útil para todos los pacientes con enfermedad de Lyme cuya condición progresó y los dejó con un daño que causa síntomas que no se pueden resolver.

. Son parte de un sistema de reparación y durante este procedimiento se enriquecen y su número aumenta., es por eso que son capaces de reconstruir las áreas dañadas dentro del organismo más, de una manera completamente natural, revertir los síntomas de una condición.

Autólogo Terapia con células madre es completamente seguro

Stem cells are undifferentiated cells that are give rise to differentiated cells that make up the building blocks of tissue and organs. Due to their unlimited source and high differentiation potential, autologous stem cells are considered as potentially new therapeutic agents for the treatment.

During past few years a considerable progress in stem cell-based strategies whole body regeneration have been proposed as future clinical therapies.

En la actualidad, most procedures involve injections of stem cells to peripheral blood like a blood transfusions.

Cuando se infunden células madre en el paciente, se administran a través de un catéter intravenoso (IV) como una transfusión de sangre.

Evaluación previa al tratamiento

Un especialista en células madre comenzará la evaluación revisando su historial médico y su historial., performing anti-aging treatment he will recommend a treatment plan.

Pruebas previas a la admisión

Antes de ser admitido en la clínica, you will have laboratory and other diagnostic tests to determine if you have normal function of the heart, pulmones, riñón e hígado y que no tiene una infección no diagnosticada. La mayoría de estas pruebas se realizarán de forma ambulatoria antes de que lo admitan en la clínica., pero es posible que deba completar otros después de su admisión para el tratamiento.

Stem Cells injections.

Cuando se infunden células madre en el paciente, se administran a través de un catéter intravenoso (IV) o catéter venoso central, como una transfusión de sangre .


It is expected strengthening the regenerative abilities of the body, improving of all functions of organs and tissues and repairing of pathologically damaged tissues, rejuvenate body.

The approximate maximum of stem cell efficiency is 2 months after injection with the subsequent long-term effect.


It is recommended do not use antibiotics for several weeks after stem cells injections.

It is not recommended to visit sauna for 1-2 semanas,  avoid strong physical activity, stresses and any kind of trauma within 2 months after stem cells injections.

Necesito más detalles?


Email: evgeniyzadorin@gmail.com

Whatsapp +33758673528

terapia con células madre